Sufferers of the debilitating bowel disease ulcerative colitis could soon benefit from a breakthrough jab originally designed to treat the skin problem psoriasis.
A major trial has shown that regular injections of mirikizumab eradicated symptoms in one in four patients after just three months, including stomach pain and the urgent need to go to the toilet.
Experts have also suggested the results are long-lasting, with patients who are given just a once-a-month maintenance dose still clear of problems after a year.
Load More
Yorumlar
Kalan Karakter: